Alisi Anna
Alisi Anna
Bambino Gesů Children's Hospital and IRCCS
Verified email at
Cited by
Cited by
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
F Del Chierico, V Nobili, P Vernocchi, A Russo, C De Stefanis, D Gnani, ...
Hepatology 65 (2), 451-464, 2017
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non‐alcoholic steatohepatitis
A Alisi, G Bedogni, G Baviera, V Giorgio, E Porro, C Paris, P Giammaria, ...
Alimentary pharmacology & therapeutics 39 (11), 1276-1285, 2014
Complications, morbidity and mortality of nonalcoholic fatty liver disease
A Mantovani, E Scorletti, A Mosca, A Alisi, CD Byrne, G Targher
Metabolism 111, 154170, 2020
I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease
L Valenti, A Alisi, E Galmozzi, A Bartuli, B Del Menico, A Alterio, ...
Hepatology 52 (4), 1274-1280, 2010
Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial
V Nobili, G Bedogni, A Alisi, A Pietrobattista, P Risé, C Galli, C Agostoni
Archives of disease in childhood 96 (4), 350-353, 2011
NAFLD in children: new genes, new diagnostic modalities and new drugs
V Nobili, A Alisi, L Valenti, L Miele, AE Feldstein, N Alkhouri
Nature reviews Gastroenterology & hepatology 16 (9), 517-530, 2019
Antioxidant effects of natural bioactive compounds
C Balsano, A Alisi
Current pharmaceutical design 15 (26), 3063-3073, 2009
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ...
Journal of hepatology 74 (4), 775-782, 2021
Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review.
V Nobili, A Alisi, N Panera, C Agostoni
Pediatric endocrinology reviews: PER 6 (2), 241-247, 2008
Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease
A Alisi, L Da Sacco, G Bruscalupi, F Piemonte, N Panera, R De Vito, ...
Laboratory investigation 91 (2), 283-293, 2011
Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cells via microRNA targeting peroxisome proliferator-activated receptor-γ
D Povero, N Panera, A Eguchi, CD Johnson, BG Papouchado, ...
Cellular and molecular gastroenterology and hepatology 1 (6), 646-663. e4, 2015
A 360-degree overview of paediatric NAFLD: recent insights
V Nobili, G Svegliati-Baroni, A Alisi, L Miele, L Valenti, P Vajro
Journal of hepatology 58 (6), 1218-1229, 2013
Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children
V Nobili, A Alisi, C Della Corte, P Risé, C Galli, C Agostoni, G Bedogni
Nutrition, Metabolism and Cardiovascular Diseases 23 (11), 1066-1070, 2013
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
V Giorgio, L Miele, L Principessa, F Ferretti, MP Villa, V Negro, A Grieco, ...
Digestive and Liver Disease 46 (6), 556-560, 2014
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents
A Mosca, V Nobili, R De Vito, A Crudele, E Scorletti, A Villani, A Alisi, ...
Journal of hepatology 66 (5), 1031-1036, 2017
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study
V Nobili, M Manco, P Ciampalini, A Alisi, R Devito, E Bugianesi, ...
Clinical therapeutics 30 (6), 1168-1176, 2008
The role of tissue macrophage‐mediated inflammation on NAFLD pathogenesis and its clinical implications
A Alisi, G Carpino, FL Oliveira, N Panera, V Nobili, E Gaudio
Mediators of inflammation 2017 (1), 8162421, 2017
Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease
V Nobili, G Carpino, A Alisi, A Franchitto, G Alpini, R De Vito, P Onori, ...
Hepatology 56 (6), 2142-2153, 2012
The system can't perform the operation now. Try again later.
Articles 1–20